Asthma Inhaler Device Market Technology, Trends, New Business Opportunities and Forecast to 2022


Market Research Report

Market Research Report

Asthma Inhaler device Information, by device type, by technology (manually operated inhaler devices, digitally operated inhaler devices), by end – Forecast 2022

PUNE, MAHARASHTRA, INDIA, February 3, 2017 /EINPresswire.com/ — Intended Audience:
o Asthma inhaler device Manufacturers
o Asthma inhaler device Suppliers
o Research and Development (R&D) Companies
o Independent Research Laboratories
o Market Research and Consulting Service Providers
o Medical Research Laboratories

Market Scenario:
Asthma is a type of inflammatory disease of the lungs. It causes difficulty while breathing and brings on attacks of coughing, wheezing, tightness in the chest and shortness of breath. It causes inside walls of an asthmatic's airways swollen or inflamed. The swelling or inflammation causes the airways extremely sensitive to irritations and increases the susceptibility to an allergic reaction. Market for Asthma inhaler device is growing it is mainly drive by the rise in the prevalence of Asthma and chronic lung disease.

Key Players
• GlaxoSmithKline (GSK) (UK)
• Merck & Co., Inc. (US)
• 3M (US)
• Aristopharma Ltd. (Dhaka)
• SRS PHARMACEUTICALS PVT. LTD. (India)
• Intas Pharmaceuticals Ltd (India)

Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1653

Market Segments
On The Basis Of Device Type
 Metered-Dose Inhaler
 MDI with a Spacer
 Dry-Powder Inhaler

On The Basis of Technology
 Manually Operated Inhaler Devices
 Digitally Operated Inhaler Devices

On The Basis of End Users
 Hospital
 Clinics
 Retailers

Study Objectives of Asthma inhaler device Market:
o To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Asthma inhaler device market

o To provide insights about factors affecting the market growth

o To analyze the Asthma Inhaler Device Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

o To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

o To provide country level analysis of the market with respect to the current market size and future prospective

o To provide country level analysis of the market for segments by type, by end users and its sub-segments.

o To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

o To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Asthma Inhaler Device Market.

Browse Report @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market

Regional Analysis of Asthma inhaler device Market:
Globally North America is the largest market for Asthma inhaler devices. The North American market for Asthma inhaler device is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. Due to the demand of sophisticated therapies by doctors and patients derived the market to a large extent. The market is steadily growing due to innovative and cost-effective products present in market. Europe is expected to be the second-largest market for Asthma inhaler device which is expected to grow at a CAGR of XX%. Asia-Pacific is anticipated to be the fastest growing region during the forecast period.

TOC Consist Following Chapters
1. Report Prologue
2. Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
2.4. Market Segmentation
3. Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Mega Trends
4.5 Macroeconomic Indicators
5. Market Factor Analysis
5.1 Value Chain Analysis
5.2 PORTERS Five Forces
5.3 Demand & supply: gap analysis
5.4 Pricing Analysis
5.5 Investment Opportunity Analysis
5.6 Merger and Acquisition Landscape
5.7 Upcoming trends in market
5.7.1 Market trends
5.7.2 Technological trends
5.7.3 Insurance & Regulations
5.7.4 Others
Continue……….

The report for Global Asthma Inhaler Device Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.

Related Report
Global Radio pharmaceutical Information, by types (Diagnostic and Therapeutic Radio pharmaceuticals) by application (cardiology, thyroid, oncology, neurology, others) by end users (hospitals, research centers, clinics)- Forecast to 2022 https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Dental Services 2017 Global Market Expected to Grow at CAGR 13.81% And Forecast To 2020

The analysts forecast the global dental services market to grow at a CAGR of 13.81% during the period 2016-2020.

PUNE, INDIA, February 3, 2017 /EINPresswire.com/ — Global Dental Services Market

Dental services market is one of the fastest emerging markets in the healthcare sector. It is one of the major revenue generators in the medical field, as it is regarded as one of the most expensive medical services being offered so far. The market is segmented based on the services offered and end-users for these dental services.

Covered in this report
The report covers the present scenario and the growth prospects of the global dental services market for 2016-2020. To calculate the market size, the report considers the revenue generated from dental implant services, orthodontic dental services, cosmetic dentistry services, periodontal dental services.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Get Sample Report @ https://www.wiseguyreports.com/sample-request/687132-global-dental-services-market-2016-2020

The Global Dental Services Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Coast Dental Services
• mydentist
• Abano Healthcare Group
• Q & M Dental Group (Singapore)

Other prominent vendors
• 1300SMILES
• American Dental Partners
• Apollo White Dental
• Aspen Dental Management
• Axiss Dental
• Birner Dental Management Services
• Brighter Dental Care
• Dental Services Group
• Enel-Med
• Floss Dental
• Folktandvården Stockholms län
• Gentle Dentistry
• Great Expressions Dental Centers
• Healthway Medical
• InterDent
• Kool Smiles
• Laboratorio Lucas Nicolas
• Midwest Dental
• Northwestern Management Services
• Novadent
• Oasis Dental Care
• Oral Care AB
• Oral Hammaslääkärit
• Orasolv AB
• Pacific Dental Services
• PlusTerveys Oy
• Praktikertjänst AB
• ReachOut Healthcare America
• Smile Brands

Market driver
• Upcoming laser dentistry and painless treatment
• For a full, detailed list, view our report

Market challenge
• High-cost factor hindering the adoption of dental services
• For a full, detailed list, view our report

Market trend
• Collaboration with leading insurance providers
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/687132-global-dental-services-market-2016-2020

Table of Contents -Major Key Points

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by services
• Dental implant services
• Orthodontic dental services
• Cosmetic dentistry
• Periodontal dental services
• Other dental services

PART 07: Market segmentation by end-users
• Hospitals
• Dental clinics

PART 08: Geographical segmentation
• Dental services market in Americas
• Dental services market in EMEA
• Dental services market in APAC

PART 09: Market drivers
• Upcoming laser dentistry and painless treatment
• Increasing demand for cosmetic dentistry and smile makeover
• Increasing prevalence of the dental diseases in teenagers and adults

PART 10: Impact of drivers

PART 11: Market challenges
• High-cost factor hindering the adoption of dental services
• Lack of services
• Lack of medical coverage for the dental services
• Migration of oral healthcare professionals

PART 12: Impact of drivers and challenges

PART 13: Market trends
• Collaboration with leading insurance providers
• Rise in medical tourism
• Usage of advanced robotic technology through dental imaging

Dental awareness campaigns
PART 14: Vendor landscape
• Competitive scenario
• Other prominent vendors

PART 15: Key vendor analysis
• Geographic presence – key vendor analysis
• Coast Dental Services
• mydentist
• Abano Healthcare Group
• Q & M Dental Group (Singapore)
• Other prominent vendors

……CONTINUED

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=687132

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Medical Sensors Market Size, Trends, Latest Innovation in Technologies, Applications Analysis and Forecast 2016-2022


Market Research Report

Market Research Report

Global Medical Sensors Market which is expected to grow at the CAGR of 8% from 2016 to 2022

PUNE, MAHARASHTRA, INDIA, February 3, 2017 /EINPresswire.com/ — Market Highlights
Medical sensors are devices which diagnosis a patient’s medical condition as well as monitor the same. These sensors increases the use of medical equipment’s such as life-supporting implants also in monitoring a patient’s vital health signs and other health factors which ultimately improves the quality of care provided to patients by avoiding complications. The Medical Sensors Market is booming due to the increasing aging population which has fueled the development of new and different types of medical equipment’s and has also increased demand for various sensors that are used in medical equipment and patients’ bodies.

On the basis of product type there are pressure sensors that are used in various medical devices such as drug delivery machines, infusion and insulin pumps, respiratory monitoring, blood pressure monitoring equipment and dental instruments. Other medical devices are temperature sensors which are used for monitoring temperature to provide unmatched accuracy and sensitivity in detecting body temperature. Image sensors are used in different types of imaging methods. Accelerometers are used in heart pacemakers and defibrillators, patient monitoring equipment, blood pressure monitors, and other integrated health monitoring equipment. Biosensors are used to diagnose glucose and cholesterol level as well as for testing for drug abuse and infectious diseases. Encoders are found in sports and healthcare equipment and other noncritical medical devices.

Kay Players
• TE Connectivity Corporation (US)
• Murata Manufacturing Co.
• Shimmer (Ireland)
• Merit Medical Systems, Inc. (US)
• Sensirion AG (Switzerland)
• Masimo Corporation (US)
• Mouser Electronics, Inc. (US)
• PreSens Precision Sensing GmbH (Germany)
• Novosense AB (Sweden)
• ST. JUDE MEDICAL (US)
• First Sensor AG
• Medtronic Plc. (Ireland)
• Measurement Specialties Inc. (U.S)
• Honeywell International, Inc. (U.S)
• Smiths Medical (U.K)

Request a Sample Report @ https://marketresearchfuture.com/sample_request/2038

Medical devices are used in various medical appliances including device, cardiovascular monitoring and diagnosis, patient monitoring, surgery/drug delivery system and many home diagnostics medical devices.

Global Medical Sensors Market:
The global medical sensors market has been evaluated to be rapidly growing and is expected to grow further in future. Factors such as increasing prevalence of chronic diseases and latest innovation in technologies will fuel the growth of the market. The global medical sensors market is expected to grow at the CAGR of 8% during in the future.

Regional Analysis:
Depending on geographic region, medical sensors market is segmented into four key regions: North America, Europe, Asia Pacific, and Middle East & Africa. Globally North America is the largest market for Medical sensors as it has the most advanced healthcare technologies along increasing demand for reliable and cost effective products. Europe is the second largest market for medical sensors. Asia Pacific region is expected to be fastest growing region of the medical sensors market due to rising awareness among patients and increasing healthcare expenditure.

Browse Report @ https://marketresearchfuture.com/reports/medical-sensors-market

Segmentation:
Global medical sensors market has been segmented on the basis of product type which comprises of pressure sensors, SQUID, temperature sensors, biosensors, image sensors, accelerometers, encoders and others. On the basis of application; market is segmented into cardiovascular monitoring, patient monitoring, diagnosis, surgical/drug delivery, home and mobile health care and others. On the basis of end-users; market is segmented into hospitals, clinics, home healthcare and others.

Intended Audience
• Medical sensors manufacturers
• Medical sensors suppliers
• CROs/CMOs
• Government Research Laboratories
• Private Research Laboratories
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers

Related Report
Home Healthcare Market information, by type (products, services, solutions), by application (wound care, patient education, nutrition therapy, monitoring, others) – Forecast to 2022 https://www.marketresearchfuture.com/reports/home-healthcare-market

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Contact Lens Systems 2017 Global Market Expected to Grow at CAGR 6.63% And Forecast To 2020

The analysts forecast the global contact lens market to grow at a CAGR of 6.63% during the period 2016-2020.

PUNE, INDIA, February 3, 2017 /EINPresswire.com/ — Global Contact Lens Market

Contact lenses are a replacement for corrective glasses due to their better aesthetic and cosmetic appeal. They are thin lenses that are placed directly on the surface of the eye and are worn to correct vision or for other therapeutic purposes. They are also worn for cosmetic reasons, particularly to change eye color.
Contact lenses can be rigid, soft, or hybrid in nature, depending on the composition of the materials used. The advantages of contact lens over corrective glasses make them suitable to wear in any weather conditions, outdoor activities, or sports.

Covered in this report
The report covers the present scenario and the growth prospects of the global contact lens market for 2016-2020.

The market is divided into the following segments based on geography:
• Americas
• APAC
• Europe
• MEA

Get Sample Report @ https://www.wiseguyreports.com/sample-request/477473-global-contact-lens-market-2016-2020

The Global Contact Lens Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Cooper
• Johnson & Johnson
• Novartis
• Valeant Pharmaceuticals

Other prominent vendors
• All Pro Intraocular Lens
• Blanchard
• Carl Zeiss
• Conforma
• Contamac
• Essilor
• Hoya
• Medennium
• Menicon
• Shanghai Hydron Contact Lens Optics
• Synergeyes
• UltraVision

Market driver
• Rise in the number of people with eye disorders
• For a full, detailed list, view our report

Market challenge
• Risk of infection
• For a full, detailed list, view our report

Market trend
• Introduction of antimicrobial contact lenses
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Complete Report Details @ https://www.wiseguyreports.com/reports/477473-global-contact-lens-market-2016-2020

Table of Contents -Major Key Points

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Product lines
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Market landscape
• Market overview
• R&D
• Market size and forecast
• Five forces analysis

PART 06: Market segmentation by product
• Market overview
• Global soft contact lens market
• Global RGP contact lens market
• Global hybrid contact lens market

PART 07: Segmentation of soft contact lens
• Market overview
• Global daily soft contact lens market
• Global weekly soft contact lens market
• Global monthly soft contact lens market
• Global other soft contact lens market

PART 08: Market segmentation by application
• Market overview
• Global corrective contact lens market
• Global therapeutic contact lens market
• Global cosmetic contact lens market

PART 09: Geographical segmentation
• Market overview
• Contact lens market in the Americas
• Contact lens market in APAC
• Contact lens market in Europe
• Contact lens market in MEA

PART 10: Buying criteria

PART 11: Market drivers

PART 12: Impact of drivers

PART 13: Market challenges

PART 14: Impact of drivers and challenges

PART 15: Market trends

PART 16: Vendor landscape
• Competitive scenario
• Market share analysis
• Industry association
• Investment opportunity analysis
• Other prominent vendors

……CONTINUED

Buy Now@ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=477473

CONTACT US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Seasonal Influenza Therapeutic and Drug Pipeline Review H2


Wise.Guy12

Wise.Guy.

Seasonal Influenza Treatment Pipeline Review H2 2017

PUNE, INDIA, February 3, 2017 /EINPresswire.com/ — Summary
Influenza, often referred to as the flu, is an acute infection caused by one of the three closely related viruses, designated as influenza Type A, B, and C. The infection’s rapid onset and potential for high morbidity and mortality, particularly in high-risk patient populations such as the elderly and young children, make prompt and effective treatment with antiviral medication very difficult. For these reasons, prophylactic vaccination is the preferred intervention for seasonal influenza.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/924357-seasonal-influenza-therapeutics-in-of-quadrivalent-therapies

In the recent years it was observed that demand for seasonal influenza vaccines have increased due to changed perception of patient population. APAC region is an attractive market for seasonal influenza vaccine manufacturers. Continuous improvements in the formulation of vaccines has occurred over the years, with the market currently transitioning from trivalent to quadrivalent formulations, which offer protection against an additional B strain of the virus. Traditional egg based manufacturing of seasonal influenza vaccines is being replaced with cell culture vaccines. Cell culture based production of vaccines is expected to reduce the problems associated with the production and use of seasonal influenza vaccines which will further increase the vaccination coverage in the APAC region.

Research analysis shows that the R&D pipeline for seasonal influenza vaccines comprises a high number of vaccines in early-stage development, many of which are new formulations or those that have been developed using the cell culture method. Late-stage vaccines are either quadrivalent vaccines or pediatric versions of those that have already been approved. Research expects that quadrivalent seasonal influenza vaccines will replace their trivalent vaccines forerunner by the end of the forecast period.

Scope
The seasonal influenza Asia-Pacific market will be valued at $1.71 billion in 2022, growing from $1.24 billion in 2015 at a CAGR of 4.7%.
Trivalent and quadrivalent vaccines dominate the seasonal influenza market, but unmet needs exist in terms of safety and efficacy.
– Will the drugs under development fulfill the unmet needs of the seasonal influenza market?
– Do quadrivalent therapies show continuous growth, and are they facing any competition from trivalent therapies?
– How will available therapies be affected by upcoming pipeline therapies?
The pipeline contains a range of molecule types and molecular targets, including those that are well established in seasonal influenza.
– Which molecular targets appear most frequently in the pipeline?
– Will the pipeline drugs fulfill the unmet needs of seasonal influenza market?
Market forecasts indicate that Japan will contribute the most to the Asia-Pacific market value, due to the emergence of quadrivalent therapies.
– How will the annual cost of therapy and market size vary between the five Asia-Pacific markets?
Various drivers and barriers will influence the market over the forecast period.
– What barriers limit the uptake of premium-priced vaccines in the assessed countries?
– What factors are most likely to drive the market in these countries?

Reasons to buy
This report will allow you to –
– Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.
– Visualize the composition of the seasonal influenza market in terms of dominant therapies, with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the current market.
– Analyze the seasonal influenza pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target.
– Understand the potential of late-stage therapies, with extensive profiles of products that could enter the market over the forecast period, highlighting clinical performance, potential commercial positioning, and how they will compete with other therapies.
– Predict seasonal influenza market growth in the five Asia-Pacific markets, with epidemiological and annual cost of therapy forecasts across India, China, Australia, South Korea and Japan, as well as analysis of the contributions of promising late-stage molecules to market growth.
– Identify commercial opportunities in the seasonal influenza deals landscape by analyzing trends in licensing and co-development deals.

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 9
2.1 Disease Introduction 10
2.2 Epidemiology 10
2.3 Symptoms 12
2.4 Etiology and Pathophysiology 13
2.4.1 Pathophysiology 14
2.5 Diagnosis 14
2.6 Prognosis 16
2.7 Treatment Options 17
2.7.1 Treatment Algorithm 17
2.7.2 Pharmacological Treatments 19
2.7.3 Non-pharmacological Treatments 21
2.7.4 Exercise 21
2.7.5 Dietary Interventions 22
3 Marketed Products 23
3.1 Overview 23
3.2 Fluarix Tetra – GlaxoSmithKline 23
3.3 FluQuadri – Sanofi Pasteur 25
3.4 Vaxigrip – Sanofi Pasteur 25
3.5 Agrippal – CSL 26
3.6 Fluad – CSL 27
3.7 Fluvax/Afluria – CSL 27
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/924357-seasonal-influenza-therapeutics-in-of-quadrivalent-therapies

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Clinical Trial Management System Market is Expected to Grow at a CAGR of 15% by 2022

Global Clinical Trial Management System Market Information, By Type, Application, By End Users – Forecast to 2022

Key Players: PAREXEL International Corporation, Wipro Limited (India), GCP-Service International Ltd. & Co. KG (Germany), Oracle (US).”

— Market Research Future

PUNE, MAHARASHTRA , INDIA , February 3, 2017 /EINPresswire.com/ — Market Research Future published a half-cooked research report on global clinical trial management system market. The global clinical trial management system market is expected to grow at a CAGR of 15% during the period 2016 to 2022.

Test the market data and market information presented through more than 60 market data tables and figures spread over 90 numbers of pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Clinical Trial Management System Market Research Report- Global Forecast to 2022”.

Market Highlights:
Clinical trial management system maintains and record the information which are used to track the clinical trials. Information extracted during clinical trials are vast and highly complex and they are need to be routinely processed through multiple regression, simulation and other models. To maintain the information scientists and industry players are working towards the development of management and maintenance of this data. The market for clinical trial management system is booming due to increasing demand for the management of the clinical trial data collected at the time of clinical research and track the milestones for the further studies to make new and improved products by the biotechnology and pharmaceutical companies.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2054

Some of the key functions of CTMS includes cataloging the history of the clinical trials associated with the organizations and individuals, site management, subject tracking among others. On the basis of type of CTMS they are segmented into standard CTMS, CTMS accelerator and customized CTMS. Standard CTMS are Out-of-the-box system without organization-specific customizations while CTMS accelerator are pre-configured version of a standard CTMS that includes requested configurations and enhanced functionality of the trials. They can satisfy many of the organization’s key requirements without additional development and the customized CTMS are those which includes standard or accelerator system that is tailored to organization specific configurations.

These are commonly used by pharmaceutical and biotechnology companies, contract research organizations and medical device companies among others.

Key Players of Clinical Trial Management System Market:
• PAREXEL International Corporation
• Wipro Limited (India)
• GCP-Service International Ltd. & Co. KG (Germany)
• Oracle (US)
• Intrinsic Clinical Systems (UK)
• Acceliant (US)
• SGS SA (Switzerland)
• Telerx (US)

Segmentation:
Global clinical trial management system market has been segmented on the basis of type which comprises of standard CTMS, CTMS accelerator, customized CTMS and others. On the basis of application; market is segmented into in house, hosted and others. On the basis of end users; market is segmented into pharmaceutical & biotechnology companies, medical devices companies, CROs and others.

Global Clinical Trial Management System Market:
The Global Clinical Trial Management System Market has been evaluated as a growing market and it is expected that the market will touch high growth figures in future. Factors such as the growing prevalence of chronic diseases and increasing advancement in clinical trial management will drive the growth of the market. The global clinical trial management system market is expected to grow with CAGR of ~15% during the forecasted period.

Brief TOC for Clinical Trial Management System:
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.5 Market Structure:
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
3.5 Macroeconomic Indicators
4 Market Factor Analysis
4.1 Porter’s five forces model
4.1.1 Bargaining Power of suppliers
4.1.2 Bargaining Power of Customer
4.1.3 Intensity of Competitor’s
4.1.4 Threat of New Entrants
Continue…

Access Report Details @ https://www.marketresearchfuture.com/reports/clinical-trial-management-system-market

Regional Analysis:
Depending on geographic region, clinical trial management system market is segmented into four key regions: North America, Europe, Asia Pacific, and Middle East & Africa. Globally North America is the largest market for Clinical trial management system as they deploy the most advanced healthcare technologies and increasing demand for the reliable and cost effective products. Europe is the second-largest market for clinical trial management system. Asia pacific region is expected to be fastest growing region in clinical trial management system market due to increasing healthcare expenditure.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Akash Anand
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

Akash Anand
Market Research Future
+1 646 845 9312
email us here


Source: EIN Presswire

Sebia SA Therapeutic and Drug Pipeline Review H2


Wise.Guy12

Wise.Guy.

Sebia SA Therapeutic Pipeline Market Review, H2 2017

PUNE, INDIA, February 3, 2017 /EINPresswire.com/ — Summary
Sebia SA(Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers for diagnosis of cancer. The company's electrophoresis program are automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It also offers scientific and technical assistance services, and field service training. Sebia's automated system for capillary electrophoresis category includes products such as capillarys 2 flex piercing, capillarys hr, neurosoft and minicap protein 6 among others. The company's products are used for the treatment of multiple myeloma, diabetes, hemoglobin disorders and alcoholisim. It markets its products through distributors to medical laboratories. Sebia is headquartered at Evry, France.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/918668-sebia-sa-product-pipeline-analysis-2016-update

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Sebia SA
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Content: Key Points
Table of Contents 2
List of Tables 4
List of Figures 5
Sebia SA Company Overview 6
Sebia SA Company Snapshot 6
Sebia SA Pipeline Products and Clinical Trials Overview 7
Sebia SA – Pipeline Analysis Overview 9
Key Facts 9
Sebia SA – Major Products and Services 10
Sebia SA Pipeline Products by Development Stage 12
Sebia SA Pipeline Products Overview 14
Capillarys 3 Tera – CDT Assay 14
Capillarys 3 Tera – CDT Assay Product Overview 14
Capillarys 3 Tera – HbA1c Capillary Blood Assay 15
Capillarys 3 Tera – HbA1c Capillary Blood Assay Product Overview 15
Capillarys 3 Tera – Hemoglobin Adult Guthrie Assay 16
Capillarys 3 Tera – Hemoglobin Adult Guthrie Assay Product Overview 16
Capillarys 3 Tera – Hemoglobin Neonatal Cord Blood Assay 17
Capillarys 3 Tera – Hemoglobin Neonatal Cord Blood Assay Product Overview 17
Capillarys 3 Tera – Hemoglobin Neonatal Guthrie Assay 18
Capillarys 3 Tera – Hemoglobin Neonatal Guthrie Assay Product Overview 18
Capillarys 3 Tera – Hemoglobin Whole Blood Assay 19
Capillarys 3 Tera – Hemoglobin Whole Blood Assay Product Overview 19
Capillarys 3 Tera Assay – Protein HR 20
Capillarys 3 Tera Assay – Protein HR Product Overview 20
Capillarys 3 Tera Assay – Urine 21
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/918668-sebia-sa-product-pipeline-analysis-2016-update

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Sinclair Pharma plc Therapeutic and Drug Pipeline Review H2


Wise.Guy12

Wise.Guy.

Sinclair Pharma plc Treatment Pipeline Review H2 2017

PUNE, INDIA, February 3, 2017 /EINPresswire.com/ — Summary
Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is a dermatology pharmaceutical company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatology products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It also offers dermal fillers for folds and lines. Its major areas of focus include aesthetics, wound care, and skin care. Some of Sinclair’s major brands include Silhouette Soft; Ellanse; Perfectha and Sculptra. The company has a presence in various countries through a network of subsidiaries. It has direct sales and marketing presence in five major European countries. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/918685-sinclair-pharma-plc-sph-product-pipeline-analysis-2016-update

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Sinclair Pharma Plc
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Content: Key Points
Table of Contents 2
List of Tables 4
List of Figures 4
Sinclair Pharma Plc Company Overview 5
Sinclair Pharma Plc Company Snapshot 5
Sinclair Pharma Plc Pipeline Products and Clinical Trials Overview 6
Sinclair Pharma Plc – Pipeline Analysis Overview 8
Business Description 8
Key Facts 9
Sinclair Pharma Plc – Major Products and Services 10
Sinclair Pharma Plc Pipeline Products by Development Stage 11
Sinclair Pharma Plc Pipeline Products Overview 15
Atlean 15
Atlean Product Overview 15
Delmopinol Coated Dental Implants 16
Delmopinol Coated Dental Implants Product Overview 16
Ellanse Hands-M 17
Ellanse Hands-M Product Overview 17
Ellanse Hands-S 18
Ellanse Hands-S Product Overview 18
Ellansé Lidocaine 19
Ellansé Lidocaine Product Overview 19
Ellansé-E 20
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/918685-sinclair-pharma-plc-sph-product-pipeline-analysis-2016-update

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Myriad Genetics Inc. Therapeutic and Drug Pipeline Review H2


Wise.Guy12

Wise.Guy.

Global Myriad Genetics Inc. Drugs and Companies Pipeline Review H2 2017

PUNE, INDIA, February 3, 2017 /EINPresswire.com/ — Summary
Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that are designed to analyze genes, their expression levels and corresponding proteins to assess a person risk for developing disease later in life, accurately diagnose disease and determine a patient’s likelihood of responding to a particular drug. It also provides an array of pharmaceutical and clinical services. Myriad markets its products through its own sales force in Europe and Canada and through distributor agreements in Latin American, Middle Eastern, Asian and African countries. The company has operations in the US, Spain, France, Switzerland, the UK, Canada, the Netherlands and Italy. Myriad is headquartered in Salt Lake City, Utah, the US.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/918683-myriad-genetics-inc-mygn-product-pipeline-analysis-2016-update

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Myriad Genetics Inc
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Content: Key Points
Table of Contents 2
List of Tables 5
List of Figures 8
Myriad Genetics Inc Company Overview 9
Myriad Genetics Inc Company Snapshot 9
Myriad Genetics Inc Pipeline Products and Clinical Trials Overview 10
Myriad Genetics Inc – Pipeline Analysis Overview 13
Business Description 13
Key Facts 14
Myriad Genetics Inc – Major Products and Services 15
Myriad Genetics Inc Pipeline Products by Development Stage 16
Myriad Genetics Inc Clinical Trials by Trial Status 19
Myriad Genetics Inc Pipeline Products Overview 21
BRACAnalysis CDx – Breast Cancer 21
BRACAnalysis CDx – Breast Cancer Product Overview 21
BRACAnalysis CDx – Ovarian Cancer 22
BRACAnalysis CDx – Ovarian Cancer Product Overview 22
BRACAnalysis CDx – Pancreatic Cancer 23
BRACAnalysis CDx – Pancreatic Cancer Product Overview 23
ChemoPredict Test 24
ChemoPredict Test Product Overview 24
Diagnostic Assay – Lung Cancer 25
Diagnostic Assay – Lung Cancer Product Overview 25
Diagnostic Assay – HER2+/TNBC-Breast Cancer 26
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/918683-myriad-genetics-inc-mygn-product-pipeline-analysis-2016-update

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Sexual Enhancement Product Global Sales Production, Revenue and Growth Rate Market Research Report 2017


Sexual Enhancement Product

Wise.Guy.

PUNE, MAHARASHTRA, INDIA, February 3, 2017 /EINPresswire.com/ — GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/917143-global-sexual-enhancement-product-sales-market-report-2017

SUMMARY

This report studies sales (consumption) of Sexual Enhancement Product in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering:

K-Y
AlphaMAN
Promescent?
XR Brands
Shibari
Astroglide
Apex

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sexual Enhancement Product in these regions, from 2011 to 2021 (forecast), like:

United States
China
Europe
Japan
Southeast Asia
India

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into:
Spray
Pills
Gel
Others

Split by applications, this report focuses on sales, market share and growth rate of Sexual Enhancement Product in each application, can be divided into:
For Adult Men
For Adult Women
For Seniors

Notes: Sales, means the sales volume of Sexual Enhancement Product
Revenue, means the sales value of Sexual Enhancement Product

ACCESS REPORT @ https://www.wiseguyreports.com/reports/917143-global-sexual-enhancement-product-sales-market-report-2017

Table of Contents

Global Sexual Enhancement Product Sales Market Report 2017

1 Sexual Enhancement Product Overview
1.1 Product Overview and Scope of Sexual Enhancement Product
1.2 Classification of Sexual Enhancement Product
1.2.1 Spray
1.2.2 Pills
1.2.3 Gel
1.2.4 Others
1.3 Application of Sexual Enhancement Product
1.3.1 For Adult Men
1.3.2 For Adult Women
1.3.3 For Seniors
1.4 Sexual Enhancement Product Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Sexual Enhancement Product (2012-2022)
1.5.1 Global Sexual Enhancement Product Sales and Growth Rate (2012-2022)
1.5.2 Global Sexual Enhancement Product Revenue and Growth Rate (2012-2022)

2 Global Sexual Enhancement Product Competition by Manufacturers, Type and Application

2.1 Global Sexual Enhancement Product Market Competition by Manufacturers
2.1.1 Global Sexual Enhancement Product Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Sexual Enhancement Product Revenue and Share by Manufacturers (2012-2017)
2.2 Global Sexual Enhancement Product (Volume and Value) by Type
2.2.1 Global Sexual Enhancement Product Sales and Market Share by Type (2012-2017)
2.2.2 Global Sexual Enhancement Product Revenue and Market Share by Type (2012-2017)
2.3 Global Sexual Enhancement Product (Volume and Value) by Regions
2.3.1 Global Sexual Enhancement Product Sales and Market Share by Regions (2012-2017)
2.3.2 Global Sexual Enhancement Product Revenue and Market Share by Regions (2012-2017)
2.4 Global Sexual Enhancement Product (Volume) by Application

3 United States Sexual Enhancement Product (Volume, Value and Sales Price)

3.1 United States Sexual Enhancement Product Sales and Value (2012-2017)
3.1.1 United States Sexual Enhancement Product Sales and Growth Rate (2012-2017)
3.1.2 United States Sexual Enhancement Product Revenue and Growth Rate (2012-2017)
3.1.3 United States Sexual Enhancement Product Sales Price Trend (2012-2017)
3.2 United States Sexual Enhancement Product Sales and Market Share by Manufacturers
3.3 United States Sexual Enhancement Product Sales and Market Share by Type
3.4 United States Sexual Enhancement Product Sales and Market Share by Application

4 China Sexual Enhancement Product (Volume, Value and Sales Price)

4.1 China Sexual Enhancement Product Sales and Value (2012-2017)
4.1.1 China Sexual Enhancement Product Sales and Growth Rate (2012-2017)
4.1.2 China Sexual Enhancement Product Revenue and Growth Rate (2012-2017)
4.1.3 China Sexual Enhancement Product Sales Price Trend (2012-2017)
4.2 China Sexual Enhancement Product Sales and Market Share by Manufacturers
4.3 China Sexual Enhancement Product Sales and Market Share by Type
4.4 China Sexual Enhancement Product Sales and Market Share by Application

5 Europe Sexual Enhancement Product (Volume, Value and Sales Price)

5.1 Europe Sexual Enhancement Product Sales and Value (2012-2017)
5.1.1 Europe Sexual Enhancement Product Sales and Growth Rate (2012-2017)
5.1.2 Europe Sexual Enhancement Product Revenue and Growth Rate (2012-2017)
5.1.3 Europe Sexual Enhancement Product Sales Price Trend (2012-2017)
5.2 Europe Sexual Enhancement Product Sales and Market Share by Manufacturers
5.3 Europe Sexual Enhancement Product Sales and Market Share by Type
5.4 Europe Sexual Enhancement Product Sales and Market Share by Application

….CONTINUED

List of Tables and Figures

Figure Picture of Sexual Enhancement Product
Table Classification of Sexual Enhancement Product
Figure Global Sales Market Share of Sexual Enhancement Product by Type in 2015
Figure Spray Picture
Figure Pills Picture
Figure Gel Picture
Figure Others Picture
Table Applications of Sexual Enhancement Product
Figure Global Sales Market Share of Sexual Enhancement Product by Application in 2015
Figure For Adult Men Examples
Figure For Adult Women Examples
Figure For Seniors Examples
Figure United States Sexual Enhancement Product Revenue and Growth Rate (2012-2022)
Figure China Sexual Enhancement Product Revenue and Growth Rate (2012-2022)
Figure Europe Sexual Enhancement Product Revenue and Growth Rate (2012-2022)
Figure Japan Sexual Enhancement Product Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Sexual Enhancement Product Revenue and Growth Rate (2012-2022)

….CONTINUED

FOR ANY QUERY, CONTACT US @ https://www.wiseguyreports.com/enquiry/917143-global-sexual-enhancement-product-sales-market-report-2017

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire